Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fusidic acid versus erythromycin after ablative fractional CO2 laser resurfacing
ChiCTR1900027000Phase 4Completed
- Sponsor
- Plastic Surgery Hospital of Chinese Academy of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fusidic acid and erythromycin in acne scar (2 arms), sponsored by Plastic Surgery Hospital of Chinese Academy of Medical Sciences. Primary endpoint: Acne scar. Started Aug 2018; status: completed.
02
Drugs
fusidic aciderythromycin
03
Conditions
acne scar
Beyond the preview
Go deeper on ChiCTR1900027000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027000.